Injection of GABA-agonist into globus pallidus in patient with Parkinson's disease

Lancet

Volumn 351, Issue 9099, 1998, Pages 340-341

  Penn, Richard D ^a,b   Kroin, Jeffrey S ^c   Reinkensmeyer, Andrea ^c   Corcos, Daniel M ^c  

^a RUSH MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; MUSCIMOL;

ADULT; ARTICLE; CASE REPORT; GLOBUS PALLIDUS; HUMAN; INTRACEREBRAL DRUG ADMINISTRATION; MALE; PALLIDOTOMY; PARKINSON DISEASE; PRIORITY JOURNAL; RIGIDITY; TREMOR;

EID: 0032583940     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78336-7     Document Type: Article

References (4)

1. 1 Baron MS, Wichmann T, DeLong MR. Inactivation of the sensorimotor territory in the internal pallidum reverses parkinsonian signs in MPTP-treated monkeys. Soc Neurosci Abstr 1992; 18: 693.
2. 2 Baron MS, Vitek JL, Bakay RAE, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996; 40: 355-66.
3. 3 Shannon KM, Penn RD, Kroin JS, et al. Stereotactic pallidotomy for the treatment of Parkinson's disease: efficacy and adverse effects at six months in 26 patients. Neurology (in press).
4. 4 Shoulson I, Goldblatt D, Charlton M, Joynt R. Huntingtons disease: treatment with muscimol, a GABA-rnirnetic drug. Ann Neurol 1978; 4: 279-84.